CoChat

SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation

Open access
Reynolds, Jessica. L., Mahajan, Supriya D. · 2021 · Journal of Neuroimmune Pharmacology
Cited by 83

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

To Emerging clinical data suggests that ~40% of COVID-19 patients develop neurological symptoms attributed to viral encephalitis, resulting in neuro-inflammation, neuronal damage and severe hypoxia (Wu et al. 2020; Najjar et al. 2020; Muccioli et al. 2020; Mao et al. 2020). SARS-COV-2 infects the host using the widely expressed angiotensin converting enzyme 2 (ACE2) receptor (Bourgonje et al. 2020), however, no there are no reports on ACE2 receptor expression by human brain microvascular endothelial cells (BMVEC) and nor-mal human astrocytes (NHA) which constitute the Blood Brain Barrier (BBB). We posit that SARS-CoV-2 enters the central nervous system (CNS) via ACE2 receptors present on BMVEC and NHA, alters tight junction (TJ) proteins leading to disruption in BBB integrity which leads to neuro-invasion of microglia. Overall, SARS-COV-2 exacerbates neuro-in-flammation, increases oxidative stress and consequently con-tributes to neuronal cell death.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11481-020-09975-y

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 83

Metadata

Authors
Reynolds, J. L., & Mahajan, S. D.
Venue
Journal of Neuroimmune Pharmacology
Published
2021-01-06
Volume
16
Issue
1
Pages
4-6
ISSN
  • 1557-1890 (ISSN-L)
  • 1557-1904
OpenAlex
W3119815596
Cited by
83
References
3
FWCI
5.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation. https://app.cochat.ai/papers/10.1007/s11481-020-09975-y
The paper
Reynolds, J. L., & Mahajan, S. D. (2021). SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation. Journal of Neuroimmune Pharmacology. https://doi.org/10.1007/s11481-020-09975-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.